Clinical Trial Update: Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pioglitazone in combination with extended-release niacin versus placebo in individuals with low HDL as part of metabolic syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Niaspan (niacin (nicotinic acid))
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-07-28